March 3, 2026Open Access

Gangliosides GM3 And GD3 Modulate Insulin Aggregation Pathways and Reduce Cytotoxicity Through Structural Remodeling

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis reveals gangliosides GD3 and GM3 reduce cytotoxicity in insulin aggregates, suggesting potential therapeutic properties.

Insulin aggregation decreases cytotoxicity, primarily mediated by gangliosides GD3 and GM3, which form non-fibrillar assemblies.
Gangliosides influence the morphology of insulin aggregates, showing a reduction in harmful effects compared to traditional fibrillar aggregates.
Analysis shows that ganglioside-bound insulin retains its seeding ability, changing the potential pathways of aggregation.
Findings suggest therapeutic implications for gangliosides in managing insulin aggregation pathways and associated cytotoxicity.

Ahmad et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

March 3, 2026Open Access

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis reveals gangliosides GD3 and GM3 reduce cytotoxicity in insulin aggregates, suggesting potential therapeutic properties.

Insulin aggregation decreases cytotoxicity, primarily mediated by gangliosides GD3 and GM3, which form non-fibrillar assemblies.
Gangliosides influence the morphology of insulin aggregates, showing a reduction in harmful effects compared to traditional fibrillar aggregates.
Analysis shows that ganglioside-bound insulin retains its seeding ability, changing the potential pathways of aggregation.
Findings suggest therapeutic implications for gangliosides in managing insulin aggregation pathways and associated cytotoxicity.

Ahmad et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark